✦ LIBER ✦

Results of a multicenter comparative study of single-dose cefotetan and multiple-dose cefoxitin as prophylaxis in patients undergoing cesarean section

✍ Scribed by Rudolph P. Galask; Benedict B. Benigno; F. Gary Cunningham; John P. Elliott; Edgar Makowski; James A. McGregor; Alfred Poindexter

Book ID: 117025660
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 471 KB
Volume: 155
Category: Article
ISSN: 0002-9610
DOI: 10.1016/s0002-9610(88)80220-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative study of single-dose cefotax

Comparative study of single-dose cefotaxime and multiple doses of cefoxitin and cefazolin as prophylaxis in gynecologic surgery

✍ Francisco Campillo; José Manuel Rubio 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Atacicept in patients with rheumatoid ar

Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study

✍ P. P. Tak; R. M. Thurlings; C. Rossier; I. Nestorov; A. Dimic; V. Mircetic; M. R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

Could steroids be withdrawn in renal tra

Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids

✍ Y Lebranchu; P Aubert; F Bayle; J Bedrossian; F Berthoux; B Bourbigot; M Buchler 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 52 KB

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

A randomized, comparative, 3-arm, parall

A randomized, comparative, 3-arm, parallel group, open-label, multicenter study of the efficacy and safety of Bravelle™ (purified human FSH) and Repronex® when mixed in the same syringe and administered subcutaneously in continuous or sequential dose ratios to patients (34–40 years) undergoing in-vitro fertilization: interim data

✍ D.C. Marshall; M. Surrey; B. VanVoorhis; D. Kenigsberg; J.H. Check; P. McShane; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 29 KB

A randomized, comparative, 3-arm, parall

A randomized, comparative, 3-arm, parallel group, open-label, multicenter study of the efficacy and safety of Bravelle™ (purified human FSH) and Repronex® when mixed in the same syringe and administered subcutaneously in continuous or sequential dose ratios to patients (18–33 years) undergoing in-vitro fertilization: interim data

✍ D.C Marshall; J.H Check; V Schnell; M Jacobs; M Yemini; S Oskowitz; J Batzofin; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 20 KB